skip to content

Department of Chemical Engineering and Biotechnology

 

Dr Kaminski Schierle has achieved the status of Higher Education Academy Senior Fellow ‘in recognition of attainment against the UK Professional Standards Framework for teaching and learning support in higher education.’

The Higher Education Academy is an independent non-profit organisation committed to world-class teaching in higher education. They work in partnership with institutions and individuals in higher education supporting student success, bringing the sector together to collaborate, and share teaching strategies and practice.

Their fellowship scheme provides a framework to support members committed to continuous professional development who wish to develop their skills and formalise their experience in higher education teaching.

Dr Kaminski Schierle is the programme director for our MPhil in Biotechnology course, which supports students with skills and experience in the physical sciences transition to apply their knowledge in biotech and pharmaceutical fields. She also leads the Molecular Neuroscience Group in our department, investigating the molecular mechanisms that can cause neurodegenerative diseases, such as Parkinson’s disease, Alzheimer's disease, and Huntington’s disease.

In achieving Senior Fellow, Dr Kaminski Schierle’s experience was assessed against the following criteria:

  1. demonstrate, impact and influence through, for example, responsibility for leading, managing or organising programmes, subjects and/or disciplinary areas;
  2. experienced subject mentors and staff who support those new to teaching;
  3. experienced staff with departmental and/or wider teaching and learning support advisory responsibilities within an institution

We would like to congratulate Dr Kaminski Schierle on her appointment and thank her for her continued dedication to teaching excellence in our department. 

Latest news

New heart valve could transform open heart surgery for millions of patients globally

29 June 2020

The new polymeric heart valve, developed by scientists at the universities of Bristol and Cambridge, prevents the need for life-long blood thinning medication.

Shaping the world

23 June 2020

CEB researchers Beth Tennyson and Jana Weber named in WES Top 50 engineers awards

Continuous synthesis of iron nanoparticles could open up their use as anti-cancer treatment

9 June 2020

PhD student, Julien Mahin, from our Process Integration group, has developed a new method to produce single-sized magnetic nanoparticles with promising medicinal applications.